Wei Mao

1.4k total citations
75 papers, 1.0k citations indexed

About

Wei Mao is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Wei Mao has authored 75 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Wei Mao's work include Hip and Femur Fractures (9 papers), MRI in cancer diagnosis (8 papers) and Advanced Neuroimaging Techniques and Applications (8 papers). Wei Mao is often cited by papers focused on Hip and Femur Fractures (9 papers), MRI in cancer diagnosis (8 papers) and Advanced Neuroimaging Techniques and Applications (8 papers). Wei Mao collaborates with scholars based in China, Singapore and Germany. Wei Mao's co-authors include Yuqin Ding, Jianjun Zhou, Minhu Chen, Jie Chen, Caixia Fu, Mengsu Zeng, Tieli Peng, Yiqun He, Linli Li and Yaqiong Wang and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Bone and Joint Surgery and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Wei Mao

66 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Mao China 18 309 232 187 176 147 75 1.0k
Qi Ma China 20 415 1.3× 59 0.3× 184 1.0× 152 0.9× 229 1.6× 96 1.0k
Philippe Garrigue France 16 185 0.6× 97 0.4× 131 0.7× 73 0.4× 77 0.5× 38 664
Lixi Li China 17 305 1.0× 69 0.3× 82 0.4× 263 1.5× 167 1.1× 79 1.0k
Ragavendra R. Baliga United States 17 585 1.9× 183 0.8× 222 1.2× 295 1.7× 197 1.3× 54 1.6k
Deanne Mickelsen United States 19 443 1.4× 70 0.3× 156 0.8× 133 0.8× 104 0.7× 31 1.2k
Katherine Sattler Germany 21 665 2.2× 140 0.6× 418 2.2× 53 0.3× 115 0.8× 40 1.5k
Toshiaki Kadokami Japan 22 528 1.7× 195 0.8× 332 1.8× 95 0.5× 129 0.9× 68 1.8k
Tien‐Hung Huang Taiwan 21 372 1.2× 44 0.2× 242 1.3× 82 0.5× 136 0.9× 37 996
Valerio D’Orazi Italy 19 224 0.7× 84 0.4× 229 1.2× 205 1.2× 76 0.5× 56 870
Michael J. Raher United States 19 448 1.4× 86 0.4× 183 1.0× 75 0.4× 322 2.2× 25 1.6k

Countries citing papers authored by Wei Mao

Since Specialization
Citations

This map shows the geographic impact of Wei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Mao more than expected).

Fields of papers citing papers by Wei Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Mao. The network helps show where Wei Mao may publish in the future.

Co-authorship network of co-authors of Wei Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Mao. A scholar is included among the top collaborators of Wei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Mao. Wei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Hong, Yuan Li, Hui Zhang, et al.. (2024). Topographic and temporal patterns of dyskinesia in multiple system atrophy with predominant parkinsonism. Journal of Neurorestoratology. 12(4). 100145–100145. 1 indexed citations
2.
Fan, Chengcheng, Chao Han, Jagadish K. Chhetri, et al.. (2024). Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis. Journal of Parkinson s Disease. 14(6). 1211–1223. 2 indexed citations
3.
Mao, Wei, et al.. (2024). Anteromedial Cortical Support in Reduction of Trochanteric Hip Fractures. Journal of Bone and Joint Surgery. 106(11). 1008–1018. 3 indexed citations
4.
Ma, Jinghong, Wei Mao, Erhe Xu, et al.. (2024). Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease: A Pilot Study. Movement Disorders Clinical Practice. 11(10). 1241–1248. 2 indexed citations
5.
6.
Huang, Lihua, Ran Cheng, Xiaowan Wang, et al.. (2023). [Leonurine inhibits ferroptosis in renal tubular epithelial cells by activating p62/Nrf2/HO-1 signaling pathway].. PubMed. 48(8). 2176–2183. 8 indexed citations
7.
Mao, Wei, Yuqin Ding, Xiaoqiang Ding, et al.. (2023). Value of T1 Mapping in the Non-invasive Assessment of Renal Pathologic Injury for Chronic Kidney Disease Patients. Magnetic Resonance in Medical Sciences. 24(1). 78–87. 4 indexed citations
8.
Zhang, Yue, et al.. (2023). Parkinsonism after ventriculoperitoneal shunt for hydrocephalus. BMC Neurology. 23(1). 38–38. 1 indexed citations
9.
Mao, Wei, et al.. (2023). Positive medial cortical support versus anatomical reduction for trochanteric hip fractures: Finite element analysis and biomechanical testing. Computer Methods and Programs in Biomedicine. 234. 107502–107502. 11 indexed citations
10.
Mao, Wei, et al.. (2023). Relative instability ratios of bone wall defects in trochanteric hip fractures: A finite element analysis. Frontiers in Bioengineering and Biotechnology. 11. 1082613–1082613. 3 indexed citations
11.
Mao, Wei, Yuqin Ding, Xiaoqiang Ding, et al.. (2022). Capability of arterial spin labeling and intravoxel incoherent motion diffusion-weighted imaging to detect early kidney injury in chronic kidney disease. European Radiology. 33(5). 3286–3294. 18 indexed citations
12.
Mao, Wei, Yuqin Ding, Xiaoqiang Ding, et al.. (2021). Diffusion kurtosis imaging for the assessment of renal fibrosis of chronic kidney disease: A preliminary study. Magnetic Resonance Imaging. 80. 113–120. 19 indexed citations
13.
Zhu, Qi, Chunhua Lu, Feixiang Xu, et al.. (2020). Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation. Clinical & Translational Oncology. 22(8). 1355–1363. 9 indexed citations
14.
Tang, Han, Yiqun He, Linli Li, et al.. (2019). Exosomal MMP2 derived from mature osteoblasts promotes angiogenesis of endothelial cells via VEGF/Erk1/2 signaling pathway. Experimental Cell Research. 383(2). 111541–111541. 50 indexed citations
15.
Zhu, Qiaoliang, Rongkui Luo, Jie Gu, et al.. (2019). High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. Journal of Cancer. 11(4). 810–818. 9 indexed citations
16.
Xu, Fengkai, Jie Gu, Chunlai Lu, et al.. (2018). Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway. International Journal of Biological Sciences. 15(1). 127–137. 28 indexed citations
17.
Xu, Fengkai, Jie Gu, Lin Wang, et al.. (2018). Up-regulation Of EIF3e Is Associated With The Progression Of Esophageal Squamous Cell Carcinoma And Poor Prognosis In Patients. Journal of Cancer. 9(7). 1135–1144. 7 indexed citations
18.
Gu, Jie, Wei Mao, Fengkai Xu, et al.. (2018). Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Cancer Letters. 443. 125–134. 48 indexed citations
19.
Xu, Xiao‐Ming, Li Wu, Qin Zhuang, et al.. (2016). Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Microvascular Research. 111. 25–31. 21 indexed citations
20.
Mao, Wei, et al.. (2012). Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1. Oncology Reports. 28(4). 1257–1262. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026